Trademarkia Logo

Canada

C$
NEUMORA
FORMALIZED

on 17 Feb 2025

Last Applicant/ Owned by

Neumora Therapeutics, Inc.

1700 Owens Str. #535San Francisco, CA 94158

US

Serial Number

2161752 filed on 24th Jan 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

NEUMORA

Trademark usage description

a house mark for pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psych Read More

Classification Information


Class [005]
A house mark for pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders.


Classification kind code

11

Class [042]
Research and development of pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders; analyzing genetic, genomic, biological and clinical data for scientific research purposes; analyzing genetic, genomic, biological and clinical data for the research and development pharmaceuticals for treating neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, brain disorders and sleep disorders via targeted drug therapies.


Classification kind code

11

Mark Details


Serial Number

2161752

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 17th Feb 2025
Search Recorded
Submitted for opposition 20
on 17th Feb 2025
Examiner's First Report
Submitted for opposition 67
on 27th Sept 2024
Agent Name Changed
Submitted for opposition 287
on 14th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 24th Jan 2022
Filed
Submitted for opposition 1
on 24th Jan 2022
Created
Submitted for opposition 31
on 24th Jan 2022
Formalized